The National Cancer Institute Clinical Trials Planning Meeting to Address Gaps in Observational and Intervention Trials for Cancer-Related Cognitive Impairment

By sjmartinez • September 10, 2024

Janelsins MC, Van Dyk K, Hartman SJ, Koll TT, Cramer CK, Lesser GJ, Barton DL, Mustian KM, Wagner LI, Ganz PA, Cole PD, Bakos A, Root JC, Hardy K, Magnuson A, Ferguson RJ, McDonald BC, Saykin AJ, Gonzalez BD, Wefel JS, Morilak DA, Dahiya S, Heijnen CJ, Conley YP, Morgans AK, Mabbott D, Monje M, Rapp SR, Gondi V, Bender C, Embry L, McCaskill Stevens W, Hopkins JO, St Germain D, Dorsey SG. The National Cancer Institute Clinical Trials Planning Meeting to Address Gaps in Observational and Intervention Trials for Cancer-Related Cognitive Impairment. J Natl Cancer Inst. 2024 Sep 9:djae209. doi: 10.1093/jnci/djae209. Epub ahead of print. PMID: 39250738.

Tags: Hematology/Oncology, Publications

Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of Disease

Fine SA, Lim SY, Siena NM, de Jesus AB, Goh T, Markus L, Russell TA, Kendal JK, Lofftus SY, Shehata MS, Dao HB, Lee A,[...]

Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint Inhibitors: Adrenal Insufficiency Is Not Always the Culprit

Shabsovich D, Kathuria-Prakash N, Zhang J, Cabral M, Lopez L, Sumal A, Drakaki A. Elevated Adrenocorticotropic Hormone After Adrenalectomy or Adrenal Ablation and Immune Checkpoint[...]

RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)

Wong MK, Milhem MM, Sacco JJ, Michels J, In GK, Couselo EM, Schadendorf D, Beasley GM, Niu J, Chmielowski B, Wise-Draper TM, Bowles TL, Tsai[...]